Primary study · included by 1 review

Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095.

Afshar-Oromieh 2017 · Afshar-Oromieh Ali, Haberkorn Uwe, Zechmann Christian, et al. · European journal of nuclear medicine and molecular imaging · 2017

Included by

Beyond [177Lu]Lu-PSMA: a meta-analysis of safety and efficacy of emerging PSMA radioligand therapy agents.

Non-Cochrane · intervention · 2026 · cited as Afshar-Oromieh 2017 · Reference list refs 21-53; Table 2; Supplementary Table 5

The review does not say which of its outcomes this study informs.

1 including review in total.